Gedeon Richter PLC
Gedeon Richter PLC (RGEDF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
rgedf · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Gedeon Richter PLC (RGEDF) measures how much investors pay for each dollar of the company's trailing earnings. RGEDF's current PE ratio of 9.48x is calculated by dividing its stock price of $39.00 by its TTM earnings per share of $1258.18. +2.6% elevated vs 5Y avg 9.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%14.1x
MedianQ3 · 75%81.1x
Max
At 9.48x, RGEDF's current P/E is lower than in 15% of its annual fiscal year readings over the past 20 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Pharmaceuticals · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Gedeon Richter PLCYou RGEDF | $7.1B | 9.48x | -34.0% | $1258.18 |
 Ansell Limited ANSLY | $2.7B | 28.42x | +97.7% | $2.80 |
 Bavarian Nordic A/S BVNKF | $2.3B | 10.67x | -25.8% | $17.59 |
 Galapagos N.V. GLPGF | $1.9B | 5.47x | -61.9% | $4.87 |
 MediPal Holdings Corporation MAHLY | $3.9B | 12.80x | -10.9% | $219.14 |
 MediPal Holdings Corporation MEPDF | $3.8B | 14.50x | +0.9% | $207.98 |
 Ryman Healthcare Limited RHCGF | $1.4B | N/A | — | -$0.17 |
Industry Average 5 peers with valid PE | — | 14.37x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 8.03x | $1263.38 | -2.7% | |
2024-12-31 FY2024 | 8.25x | $1307.23 | -17.5% | |
2023-12-31 FY2023 | 10.01x | $859.72 | +22.9% | |
2022-12-31 FY2022 | 8.14x | $907.39 | -30.9% | |
2021-12-31 FY2021 | 11.78x | $750.65 | +4.6% | |
2020-12-31 FY2020 | 11.26x | $562.90 | -47.4% | |
2019-12-31 FY2019 | 21.40x | $253.40 | -24.4% | |
2018-12-31 FY2018 | 28.29x | $189.72 | -65.1% | |
2017-12-31 FY2017 | 81.14x | $47.71 | +557.2% | |
2016-12-31 FY2016 | 12.35x | $356.21 | -17.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Gedeon Richter PLC (RGEDF) measures how much investors pay for each dollar of the company's trailing earnings. RGEDF's current PE ratio of 9.48x is calculated by dividing its stock price of $39.00 by its TTM earnings per share of $1258.18.
Frequently asked questions
RGEDF pe ratio · 6 questionsRGEDF's current PE ratio is 9.48x as of 2026-06-09, based on a stock price of $39.00 and TTM EPS of $1258.18. Data sourced from Financial Modeling Prep via RGEDF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Gedeon Richter PLC SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09